Havrdova, E <br/><br/>
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.  [electronic resource] 

 -  Multiple sclerosis (Houndmills, Basingstoke, England)  Aug 2009 
 - 965-76 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1352-4585 
<br/><br/><label>Standard No.: </label>10.1177/1352458509105229  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adrenal Cortex Hormones--administration & dosage<br/>Atrophy<br/>Azathioprine--administration & dosage<br/>Brain--pathology<br/>Disability Evaluation<br/>Disease Progression<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Humans<br/>Immunologic Factors--administration & dosage<br/>Immunosuppressive Agents--administration & dosage<br/>Injections, Intramuscular<br/>Interferon beta-1a<br/>Interferon-beta--administration & dosage<br/>Magnetic Resonance Imaging<br/>Multiple Sclerosis, Relapsing-Remitting--diagnosis<br/>Prednisone--administration & dosage<br/>Prospective Studies<br/>Recurrence<br/>Time Factors<br/>Treatment Outcome